Related Experiment Video
Updated: Dec 7, 2025

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Thirty-day readmission rates and associated risk factors after coronary artery bypass grafting
Mohammad A Alghafees1, Noura A Alsubaie1, Linah K Alsadoon1
1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, KSA.
Insights
Coronary artery bypass grafting (CABG) readmission rates are 16.1%. Key risk factors include diabetes mellitus, asthma, hyperlipidemia, and certain medications like amiodarone, statins, and amlodipine.
Area of Science:
- Cardiovascular Surgery
- Health Services Research
- Clinical Outcomes
Background:
- Coronary artery bypass grafting (CABG) is a common cardiac surgery.
- High 30-day readmission rates post-CABG increase healthcare costs.
- Identifying readmission risk factors is crucial for improving patient outcomes.
Purpose of the Study:
- To determine the 30-day readmission rate following CABG.
- To identify significant risk factors associated with 30-day readmissions in CABG patients.
Main Methods:
- Retrospective cohort study at King Abdulaziz Medical City.
- Included adult patients who underwent CABG between January 2016 and January 2019.
- Utilized logistic regression to analyze readmission risk factors.
Main Results:
- The overall 30-day readmission rate was 16.1% (86 out of 534 patients).
- Significant risk factors for readmission included diabetes mellitus (P=.002), asthma (P<.001), and hyperlipidemia (P=.04).
- Medications such as amiodarone (P=.04), statins (P=.04), and amlodipine (P=.006) were also associated with readmission.
Conclusions:
- The 30-day readmission rate after CABG is 16.1%.
- Diabetes, asthma, hyperlipidemia, and use of amiodarone, statins, and amlodipine are linked to readmission.
- Further research is needed to develop strategies for reducing CABG readmissions.
Objectives:
Coronary artery bypass grafting (CABG) is among the most frequently performed cardiac surgical procedures. However, it is associated with high readmission rates for a plethora of causes, which can substantially increase healthcare costs. This study aimed to assess the rates and associated risk factors of 30-day readmissions for CABG patients.
Methods:
We conducted this retrospective cohort study at King Abdulaziz Medical City. The study targeted adult patients who underwent CABG between January 1, 2016, and January 31, 2019. Data were extracted from the BEST Care system. Frequencies and percentages were generated for categorical variables. Mean and standard deviation were calculated for quantitative variables. Bivariable and multivariable logistic regressions were used to detect readmission risk factors.
Results:
Among 534 adult patients, the overall 30-day readmission rate was 16.1% (n = 86). The multivariable logistic regression analysis showed that diabetes mellitus (P = .002), amiodarone use (P = .04), statin use (P = .04), amlodipine use (P = .006), asthma (P < .001), and hyperlipidemia (P = .04) were significantly correlated with 30-day readmission.
Conclusions:
Our study showed an estimated 16.1% 30-day readmission rate after CABG. Diabetes mellitus, asthma, hyperlipidemia, and use of medications such as amiodarone, statins, and amlodipine were associated with readmission. Further studies are needed to develop tailored and practical strategies to reduce CABG readmissions and mitigate patient and health care facility burdens.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Aneurysm III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

